Profit from Canadian-Based Biotechs and Specialty Pharmas: Philippa Flint
Profit from Canadian-Based Biotechs and Specialty Pharmas: Philippa Flint
Source: George S. Mack of The Life Sciences Report (7/12/12)
http://www.thelifesciencesreport.com/pub/na/13846
Covering a wide variety of small biotech and pharma companies domiciled in Canada, Bloom Burton & Co. Research Analyst Philippa Flint discusses important biotech and specialty pharma names that she knows quite well and expects to be very profitable for investors. In this exclusive interview with The Life Sciences Report, Flint explains in depth why her favorite companies should be in your portfolio.
Read More on International Business Times
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.